In the United Kingdom, the cost of G-CSF prophylaxis during breast cancer chemotherapy has been estimated at £3100–£5900 per patient, for six cycles (All Wales Medicines Strategy Group, 2008). This evidence concerns the gene CSF3 and breast carcinoma.